statin2025_44 {pvEBayes}R Documentation

FDA statin dataset with 44 adverse events

Description

An adverse event-drug count dataset (contingency table) obtained from the FDA FAERS database for the quarters 2021Q1 - 2024Q4.

Usage

statin2025_44

Format

An object of class matrix (inherits from array) with 45 rows and 7 columns.

Details

Data are stored in the form of a contingency table, with drugs listed across the columns and the 44 AEs presented across the rows. Each cell in the contingency table represents the total report counts associated with that (AE, drug) pair and detected in the FDA FAERS database during 2021Q1 - 2024Q4.

The dataset catalogs 6 statin drugs (across columns):

Atorvastatin, Fluvastatin, Lovastatin, Pravastatin, Rosuvastatin, Simvastatin.

The 44 adverse events presented across the rows are considered significant by FDA.

This dataset is an updated version of statin46 from the pvLRT package which collect the same scope of AEs for 6 statin drugs for quarters 2014Q3 - 2020Q4.

During 2021Q1 - 2024Q4, there was no AE report for "BLOOD CREATINE PHOSPHOKINASE MM INCREASED" and "MYOGLOBIN BLOOD PRESENT". Therefore, these two AEs are not presented in the statin2025_44 dataset.

Source

https://fis.fda.gov/extensions/FPD-QDE-FAERS/FPD-QDE-FAERS.html


[Package pvEBayes version 0.1.1 Index]